Start with the evidence.
Keep your research connected.
For analysts following 5–10 U.S.-listed biotech companies. Explore the Free research workflow first. Starter is the planned monthly option for a focused coverage list and eligible monitoring and export features.
Starter checkout is not yet available · Free access is available
Monthly billing only. Annual plans are not offered until annual checkout prices are configured and verified.
Paid activation is currently unavailable. You can explore Free access or request a Starter launch update without adding a payment card. Analyst is not available for purchase.
Review the Evidence Quality page for source coverage, freshness, conflicts, and missing evidence. These measures describe research provenance, not investment attractiveness or future performance.
Want a checkout update? Join the Starter launch list. This requests one launch update; it does not grant beta or paid access.
Starter checkout is live · facts-only, not investment advice
Monthly billing only. Annual plans are not offered until annual checkout prices are configured and verified.
Analyst is not available for purchase.
Review the Evidence Quality page for source coverage, freshness, conflicts, and missing evidence. These measures describe research provenance, not investment attractiveness or future performance.
Pricing tiers
Free
- Up to 5 production analysis requests per day
- Company and clinical-trial source evidence
- Saved briefs you can reopen
- 3 private research notes with up to 3 linked sources
- Visible source gaps and limitations
Starter
- Coverage list of up to 10 companies
- Up to 20 pipelines or clinical trials
- Recorded source changes where monitoring is available
- 30 on-demand evidence reports / month
- Available change history and original source links
- 100 active notebook notes and 20 linked source records
- Field-level review queue and revocable public citations
- Notebook export in Markdown and JSON
- PDF and CSV export
- Single user
Terms apply to billing and cancellation policy.
Start with the access available today.
Starter is the planned monthly subscription for independent researchers. Paid activation is not yet available. You can review the workspace, sources, and sample reports before deciding whether the plan fits your work.
Join the $29 Starter launch list
Request an email when Starter checkout becomes available. No payment card is required. We will use this signup to send the launch update you requested.
Capability status
Operational status is shown separately from product positioning: Available, Coming Soon, and Future Vision are never presented as equivalent.
* Standard coverage. Large-cap companies with unusually broad clinical pipelines can take longer while ORION processes the additional source material.
Optional: Starter and future Analyst scope
Starter is the current individual workflow. Analyst remains future direction.
The table preserves the product boundary without presenting Analyst as a service available for purchase today.
Questions, answered straight
Is this investment advice?
No. ORION is a research tool. It surfaces, structures, and summarizes public clinical and regulatory data so you can form your own view. It does not make trades or give personalized recommendations.
Where does the data come from?
Public clinical-trial records, regulatory records, and company disclosures. Inspect the links and evidence scope in each brief. A retrieved record or source link does not independently validate every generated statement.
What makes ORION different from a database or general AI chatbot?
ORION does not claim to replace a comprehensive commercial database. It is a research workflow that resolves biotech entities, organizes returned evidence into a consistent brief, preserves source links and timestamps, and keeps missing or conflicting facts visible.
What exactly am I paying $29 for?
Starter is planned at $29 per month for one analyst: a coverage list of up to 10 companies and 20 pipelines or trials, 30 on-demand reports per month, saved briefs, eligible exports, and recorded changes where monitoring is available. Collection status, source dates, and missing evidence matter: coverage is not complete or guaranteed in real time. Paid activation remains unavailable while checkout approval is pending.
Is Analyst available now?
No. Analyst is a Coming Soon product direction for proactive scientific intelligence. It is not currently for sale, and ORION does not imply that continuous monitoring is operating for Analyst customers today.
Can I cancel anytime?
Monthly self-serve plans cancel at the end of the current billing cycle. Annual billing is not currently offered. Guided-pilot terms, if any, are confirmed separately in writing.
Do you offer a trial?
The Free plan is the trial - up to 5 production analysis requests a day, no card required, with source-linked research and saved briefs. Free does not include ongoing source-change monitoring or PDF/CSV exports. Creating a Free account does not activate Starter. Source availability can vary and missing inputs remain explicitly unavailable.
Is there a methodology document for compliance review?
Yes — source selection, freshness rules, conflict handling, missing-data behavior, and disclosed limitations are in the Methodology Whitepaper, downloadable as a PDF for institutional due diligence.
What does a Full-Access report actually look like?
See a full worked example — Watchtower monitoring results and an immutable evidence record — on the sample report page. It uses an illustrative demo company and is clearly watermarked as a sample.